These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1872 related items for PubMed ID: 11912387

  • 1. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis.
    Heidenreich A, Varga Z, Von Knobloch R.
    J Urol; 2002 Apr; 167(4):1681-6. PubMed ID: 11912387
    [Abstract] [Full Text] [Related]

  • 2. Detecting lymph nodes metastasis in prostate cancer through extended vs. standard laparoscopic pelvic lymphadenectomy.
    Arenas LF, Füllhase C, Boemans P, Fichtner J.
    Aktuelle Urol; 2010 Jan; 41 Suppl 1():S10-4. PubMed ID: 20094944
    [Abstract] [Full Text] [Related]

  • 3. Is a limited lymphadenectomy targeting obturator nodes alone an adequate procedure for Japanese men undergoing radical prostatectomy?
    Miyake H, Sakai I, Harada K, Hara I, Eto H.
    Int J Urol; 2005 Aug; 12(8):739-44. PubMed ID: 16174048
    [Abstract] [Full Text] [Related]

  • 4. Impact of surgical volume on the rate of lymph node metastases in patients undergoing radical prostatectomy and extended pelvic lymph node dissection for clinically localized prostate cancer.
    Briganti A, Capitanio U, Chun FK, Gallina A, Suardi N, Salonia A, Da Pozzo LF, Colombo R, Di Girolamo V, Bertini R, Guazzoni G, Karakiewicz PI, Montorsi F, Rigatti P.
    Eur Urol; 2008 Oct; 54(4):794-802. PubMed ID: 18514383
    [Abstract] [Full Text] [Related]

  • 5. Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only.
    Steven K, Poulsen AL.
    J Urol; 2007 Oct; 178(4 Pt 1):1218-23; discussion 1223-4. PubMed ID: 17698113
    [Abstract] [Full Text] [Related]

  • 6. Laparoscopic extended pelvic lymph node dissection for prostate cancer: description of the surgical technique and initial results.
    Lattouf JB, Beri A, Jeschke S, Sega W, Leeb K, Janetschek G.
    Eur Urol; 2007 Nov; 52(5):1347-55. PubMed ID: 17507150
    [Abstract] [Full Text] [Related]

  • 7. [The role of pelvic lymphadenectomy in the therapy of prostate and bladder cancer].
    Heidenreich A, Ohlmann CH.
    Aktuelle Urol; 2005 Jun; 36(3):219-29. PubMed ID: 16001337
    [Abstract] [Full Text] [Related]

  • 8. Laparoscopic extended pelvic lymph node dissection for high-risk prostate cancer.
    Wyler SF, Sulser T, Seifert HH, Ruszat R, Forster TH, Gasser TC, Bachmann A.
    Urology; 2006 Oct; 68(4):883-7. PubMed ID: 17070376
    [Abstract] [Full Text] [Related]

  • 9. Incidence of positive pelvic lymph nodes in patients with prostate cancer, a prostate-specific antigen (PSA) level of < or =10 ng/mL and biopsy Gleason score of < or =6, and their influence on PSA progression-free survival after radical prostatectomy.
    Weckermann D, Goppelt M, Dorn R, Wawroschek F, Harzmann R.
    BJU Int; 2006 Jun; 97(6):1173-8. PubMed ID: 16686707
    [Abstract] [Full Text] [Related]

  • 10. Is pelvic lymph node dissection necessary in patients with a serum PSA<10ng/ml undergoing radical prostatectomy for prostate cancer?
    Schumacher MC, Burkhard FC, Thalmann GN, Fleischmann A, Studer UE.
    Eur Urol; 2006 Aug; 50(2):272-9. PubMed ID: 16632187
    [Abstract] [Full Text] [Related]

  • 11. Validation of a nomogram predicting the probability of lymph node invasion based on the extent of pelvic lymphadenectomy in patients with clinically localized prostate cancer.
    Briganti A, Chun FK, Salonia A, Gallina A, Farina E, Da Pozzo LF, Rigatti P, Montorsi F, Karakiewicz PI.
    BJU Int; 2006 Oct; 98(4):788-93. PubMed ID: 16796698
    [Abstract] [Full Text] [Related]

  • 12. Standard versus limited pelvic lymph node dissection for prostate cancer in patients with a predicted probability of nodal metastasis greater than 1%.
    Touijer K, Rabbani F, Otero JR, Secin FP, Eastham JA, Scardino PT, Guillonneau B.
    J Urol; 2007 Jul; 178(1):120-4. PubMed ID: 17499306
    [Abstract] [Full Text] [Related]

  • 13. The extent of lymphadenectomy for pTXNO prostate cancer does not affect prostate cancer outcome in the prostate specific antigen era.
    DiMarco DS, Zincke H, Sebo TJ, Slezak J, Bergstralh EJ, Blute ML.
    J Urol; 2005 Apr; 173(4):1121-5. PubMed ID: 15758719
    [Abstract] [Full Text] [Related]

  • 14. Sentinel lymph node dissection for prostate cancer: experience with more than 1,000 patients.
    Weckermann D, Dorn R, Trefz M, Wagner T, Wawroschek F, Harzmann R.
    J Urol; 2007 Mar; 177(3):916-20. PubMed ID: 17296375
    [Abstract] [Full Text] [Related]

  • 15. Robotic extended pelvic lymphadenectomy for intermediate- and high-risk prostate cancer.
    Yuh BE, Ruel NH, Mejia R, Wilson CM, Wilson TG.
    Eur Urol; 2012 May; 61(5):1004-10. PubMed ID: 22366188
    [Abstract] [Full Text] [Related]

  • 16. Anatomical extent of pelvic lymphadenectomy in patients undergoing radical prostatectomy.
    Heidenreich A, Ohlmann CH, Polyakov S.
    Eur Urol; 2007 Jul; 52(1):29-37. PubMed ID: 17448592
    [Abstract] [Full Text] [Related]

  • 17. Percentage of positive biopsy cores can improve the ability to predict lymph node invasion in patients undergoing radical prostatectomy and extended pelvic lymph node dissection.
    Briganti A, Karakiewicz PI, Chun FK, Gallina A, Salonia A, Zanni G, Valiquette L, Graefen M, Huland H, Rigatti P, Montorsi F.
    Eur Urol; 2007 Jun; 51(6):1573-81. PubMed ID: 17293026
    [Abstract] [Full Text] [Related]

  • 18. A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer.
    Cagiannos I, Karakiewicz P, Eastham JA, Ohori M, Rabbani F, Gerigk C, Reuter V, Graefen M, Hammerer PG, Erbersdobler A, Huland H, Kupelian P, Klein E, Quinn DI, Henshall SM, Grygiel JJ, Sutherland RL, Stricker PD, Morash CG, Scardino PT, Kattan MW.
    J Urol; 2003 Nov; 170(5):1798-803. PubMed ID: 14532779
    [Abstract] [Full Text] [Related]

  • 19. Critical assessment of ideal nodal yield at pelvic lymphadenectomy to accurately diagnose prostate cancer nodal metastasis in patients undergoing radical retropubic prostatectomy.
    Briganti A, Chun FK, Salonia A, Gallina A, Zanni G, Scattoni V, Valiquette L, Rigatti P, Montorsi F, Karakiewicz PI.
    Urology; 2007 Jan; 69(1):147-51. PubMed ID: 17270638
    [Abstract] [Full Text] [Related]

  • 20. Validation of a nomogram predicting the probability of lymph node invasion among patients undergoing radical prostatectomy and an extended pelvic lymphadenectomy.
    Briganti A, Chun FK, Salonia A, Zanni G, Scattoni V, Valiquette L, Rigatti P, Montorsi F, Karakiewicz PI.
    Eur Urol; 2006 Jun; 49(6):1019-26; discussion 1026-7. PubMed ID: 16530933
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 94.